Skip to content
★ Sign in to follow
RH

Russell H. Plumb

Inhibitex IncVaxart, Inc.
Total declarations
19
Companies
2
▲ Purchases (7 ops.)
€76k
▼ Sales (1 ops.)
€149k

Latest filing published 18 Sept 2015 for Vaxart, Inc., €27k.

Insider track record

Disclosed buys
7
Disclosed sells
1
Signal history

No signal scores available.

Closed purchases

Market purchases
7
Positive at T+90
0%
Median T+90
-29.0%

Based on 4 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.

Purchases by company

Since each purchase

  • Filed 12 Jun 2014 · 4533 days ago · €4,885
    -36.7%
    Entry US$35.64 · Close at T+365 US$22.55

Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.

Russell H. Plumb: trading record in brief

Russell H. Plumb discloses dealings in 2 companies, chiefly Inhibitex Inc and Vaxart, Inc. We count 19 filings; the first trade dates from 10 January 2006 and the latest from 16 September 2015.

Market trades split into 7 purchases (€76k) and 1 sale (€149k). Netting one side against the other leaves €73k of net selling. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Other entries cover 9 share grants and 2 option exercises.

A typical purchase (the median) is worth €4,885. After 4 purchases with a full 90-day history, the hit rate stands at 0% and the median 90-day move at -29.0%. These figures describe past trades and do not predict future prices.

The latest filing, published on 18 September 2015, reports a share grant of €27k in Vaxart, Inc. The clock since the last published purchase (12 June 2014) now reads 4,533 days. The median gap between a trade and its publication by SEC (Form 4) is 2 days. For comparison, the SEC allows two business days to file a Form 4. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.

Companies and markets linked to Russell H. Plumb

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations18 total
  • ◆
    Executive ChairmanExecutivesVaxart, Inc.
    30,229 USD0SEC
    12,140 shares@ US$2.49Common StockSEC:0001437749-15-017466:0
  • ◆
    Vice ChairmenExecutivesVaxart, Inc.
    98,000 USD0SEC
    40,000 shares@ US$2.45Restricted Stock UnitSEC:0001209191-14-061071:0
  • ▲
    CEO & PresidentExecutivesVaxart, Inc.
    6,615 USD0SEC
    2,700 shares@ US$2.45Common StockSEC:0001209191-14-040912:0
    Canonical exit: 8 Sept 2014 (T+90)
  • ▲
    CEO & PresidentExecutivesVaxart, Inc.
    12,083 USD0SEC
    4,331 shares@ US$2.79Common StockSEC:0001209191-14-040912:1
    Canonical exit: 9 Sept 2014 (T+90)
  • ▲
    CEO & PresidentExecutivesVaxart, Inc.
    6,907 USD0SEC
    2,310 shares@ US$2.99Common StockSEC:0001209191-14-040912:2
    Canonical exit: 9 Sept 2014 (T+90)
  • ▲
    CEO & PresidentExecutivesVaxart, Inc.
    70,112 USD0SEC
    22,690 shares@ US$3.09Common StockSEC:0001209191-14-040912:3
    Canonical exit: 9 Sept 2014 (T+90)
  • ◆
    CEO & PresidentExecutivesVaxart, Inc.
    0SEC
    143,322 shares0Common StockSEC:0001209191-12-053100:0
  • ◇
    CEO, Chief Executive OfficerExecutivesInhibitex Inc
    6,200 USD0SEC
    2,627 shares@ US$2.36Common StockSEC:0001209191-11-007447:0
  • ◇
    CEO, Chief Executive OfficerExecutivesInhibitex Inc
    18,382 USD0SEC
    10,504 shares@ US$1.75Common StockSEC:0001209191-10-042718:0
  • ◆
    CEO, Chief Executive OfficerExecutivesInhibitex Inc
    3,213 USD0SEC
    10,710 shares@ US$0.30Common StockSEC:0001209191-09-002254:0
  • ▲
    CEO, Chief Executive OfficerExecutivesInhibitex Inc
    1,805 USD0SEC
    7,400 shares@ US$0.2439Common StockSEC:0001209191-08-063858:0
    Canonical exit: 2 Mar 2009 (T+90)
  • ▲
    CEO, Chief Executive OfficerExecutivesInhibitex Inc
    1,387 USD0SEC
    5,600 shares@ US$0.2476Common StockSEC:0001209191-08-063143:0
    Canonical exit: 23 Feb 2009 (T+90)
  • ▲
    CEO, Chief Executive OfficerExecutivesInhibitex Inc
    3,536 USD0SEC
    16,600 shares@ US$0.213Common StockSEC:0001209191-08-062206:0
    Canonical exit: 18 Feb 2009 (T+90)
  • ◆
    CEO, Chief Executive OfficerExecutivesInhibitex Inc
    11,262 USD0SEC
    17,064 shares@ US$0.66Common StockSEC:0001209191-08-025962:0
  • ◆
    CEO, Chief Executive OfficerExecutivesInhibitex Inc
    35,237 USD0SEC
    49,630 shares@ US$0.71Common StockSEC:0001209191-08-023241:0
  • ◆
    CEO, Chief Executive OfficerExecutivesInhibitex Inc
    495,600 USD0SEC
    280,000 shares@ US$1.77Restricted StockSEC:0001209191-06-066745:0
  • ◆
    CFO, VP of Admin. & FinanceExecutivesInhibitex Inc
    150,470 USD0SEC
    73,400 shares@ US$2.05Restricted StockSEC:0001209191-06-026166:0
  • ▼
    CFO, VP of Admin. & FinanceExecutivesInhibitex Inc
    180,000 USD0SEC
    20,000 shares@ US$9.00Common StockSEC:0001209191-06-003094:0

18 of 18 declarations